Carlsmed vs Shoulder Innovations
CARL and SI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARL and SI compare
Carlsmed and Shoulder Innovations are about the same size, with market caps of $408M and $398M.
Carlsmed grew revenue faster over the last twelve months (65.4% versus 60.9% for Shoulder Innovations).
Carlsmed keeps more of each dollar of sales as profit, with a net margin of −57.4% compared with −58.3% at Shoulder Innovations.
Shoulder Innovations scores higher on the StockData Score (7 against 5 for Carlsmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARL | SI |
|---|---|---|
| Size and price | ||
| Market cap | $408M | $398M |
| Share price | $14.95 | $19.13 |
| Change, 1 year | 19.5% | 63.2% |
| Beta (5Y) | 2.09 | – |
| Employees | 24 | 75 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 3 | 3 |
| Performance score | 0 | 0 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.4× (better) | 6.6× |
| P/B | 4.8× | 3.2× (better) |
| FCF yield | −8.5% (better) | −11.8% |
| Fair value | $7.99 | $13.26 |
| Margin of safety | −87.2% | −44.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 65.4% (better) | 60.9% |
| Profitability | ||
| Gross margin | 76.6% | 77.3% (better) |
| Operating margin | −61.1% | −58.5% (better) |
| Net margin | −57.4% (better) | −58.3% |
| FCF margin | −54.6% (better) | −78.4% |
| Return on equity | −6197% | −152% (better) |
| Financial health | ||
| Debt / equity | – | 0.12 |
| Interest coverage | −29.0× | – |
| Current ratio | 8.84 | 10.71 (better) |
| Altman Z-score | 6.23 | 8.18 (better) |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 20.9% | 39.8% |
| Held by insiders | 81.1% | 39.9% |
| Insider net buying, 12 months | −$2.6M (better) | −$5.3M |
| Short interest, % of float | 20.4% | 5.0% |
Go deeper
- CARL stock overview
- CARL income statement
- CARL valuation and score
- SI stock overview
- SI income statement
- SI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.